Table of Content

Table of Contents

Global CAR-T Cellular Immunotherapy Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global CAR-T Cellular Immunotherapy Market by Value
2.2.1 Global CAR-T Cellular Immunotherapy Revenue by Type
2.2.2 Global CAR-T Cellular Immunotherapy Market by Value (%)
2.3 Global CAR-T Cellular Immunotherapy Market by Production
2.3.1 Global CAR-T Cellular Immunotherapy Production by Type
2.3.2 Global CAR-T Cellular Immunotherapy Market by Production (%)

3. The Major Driver of CAR-T Cellular Immunotherapy Industry
3.1 Historical & Forecast Global CAR-T Cellular Immunotherapy Demand
3.2 Largest Application for CAR-T Cellular Immunotherapy (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional CAR-T Cellular Immunotherapy Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of CAR-T Cellular Immunotherapy Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia CAR-T Cellular Immunotherapy Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global CAR-T Cellular Immunotherapy Average Price Trend
12.1 Market Price for Each Type of CAR-T Cellular Immunotherapy in US (2018-2022)
12.2 Market Price for Each Type of CAR-T Cellular Immunotherapy in Europe (2018-2022)
12.3 Market Price for Each Type of CAR-T Cellular Immunotherapy in China (2018-2022)
12.4 Market Price for Each Type of CAR-T Cellular Immunotherapy in Japan (2018-2022)
12.5 Market Price for Each Type of CAR-T Cellular Immunotherapy in India (2018-2022)
12.6 Market Price for Each Type of CAR-T Cellular Immunotherapy in Korea (2018-2022)
12.7 Market Price for Each Type of CAR-T Cellular Immunotherapy in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 CAR-T Cellular Immunotherapy Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of CAR-T Cellular Immunotherapy

14. CAR-T Cellular Immunotherapy Competitive Landscape
14.1 Fosun Kite Biotechnology
14.1.1 Fosun Kite Biotechnology Company Profiles
14.1.2 Fosun Kite Biotechnology Product Introduction
14.1.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Gilead Sciences
14.2.1 Gilead Sciences Company Profiles
14.2.2 Gilead Sciences Product Introduction
14.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Novartis
14.3.1 Novartis Company Profiles
14.3.2 Novartis Product Introduction
14.3.3 Novartis CAR-T Cellular Immunotherapy Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Bristol-Myers Squibb
14.4.1 Bristol-Myers Squibb Company Profiles
14.4.2 Bristol-Myers Squibb Product Introduction
14.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of CAR-T Cellular Immunotherapy Industry (Volume)
Figure 2. CAR-T Cellular Immunotherapy Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by CAR-T Cellular Immunotherapy Revenue in 2022
Figure 5. US CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia CAR-T Cellular Immunotherapy Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. CAR-T Cellular Immunotherapy Revenue, by Type (Million USD) (2018-2028)
Table 4. CAR-T Cellular Immunotherapy Production, by Type (K Unit) (2018-2028)
Table 5. CAR-T Cellular Immunotherapy Demand (K Unit) by Application (2018-2028)
Table 6. CAR-T Cellular Immunotherapy Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top CAR-T Cellular Immunotherapy Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia CAR-T Cellular Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of CAR-T Cellular Immunotherapy in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Fosun Kite Biotechnology Profiles
Table 61. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Introduction
Table 62. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Fosun Kite Biotechnology Strategic initiatives
Table 64. Gilead Sciences Profiles
Table 65. Gilead Sciences CAR-T Cellular Immunotherapy Product Introduction
Table 66. Gilead Sciences CAR-T Cellular Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Gilead Sciences Strategic initiatives
Table 68. Novartis Profiles
Table 69. Novartis CAR-T Cellular Immunotherapy Product Introduction
Table 70. Novartis CAR-T Cellular Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Novartis Strategic initiatives
Table 72. Bristol-Myers Squibb Profiles
Table 73. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Introduction
Table 74. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Bristol-Myers Squibb Strategic initiatives